GLOW
MOTS-c 10mg
MOTS-c
€79.00
Purity ≥99% · verified by HPLC and mass spectrometry
Order via TelegramIndependent HPLC and mass spectrometry report.
Tracked shipping to the United Kingdom, Ireland and the rest of Europe · handling 0–1 days · 14-day right of withdrawal
Technical specification
| CAS number | 1627580-64-6 |
|---|---|
| Sequence | Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg |
| Molecular formula | C101H152N28O22S2 |
| Molecular weight | 2174.6 g/mol |
| Purity | ≥99% |
| Presentation | Lyophilised powder, single-use glass vial |
| Intended use | Laboratory research use only |
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome, specifically within the 12S rRNA region, making it one of a small class of peptides referred to as mitochondrial-derived peptides. It was first characterised in metabolic research examining insulin sensitivity and has since become a focus of exercise physiology and ageing research.
The literature on MOTS-c examines its role as a signalling molecule that appears to translocate to the nucleus under metabolic stress, where research has reported interactions with stress-responsive transcription factors. This positions MOTS-c as a research tool for studying communication between mitochondrial and nuclear genomes in metabolic regulation.
Research applications
- Mitochondrial-nuclear signalling research
- Insulin sensitivity and glucose metabolism studies in rodent models
- Exercise physiology and skeletal muscle metabolism research
- AMPK pathway activation studies
What the literature reports on MOTS-c
MOTS-c was identified through a screen of small open reading frames within mitochondrial DNA and is classified among the mitochondrial-derived peptides, a group that also includes humanin. Its discovery and initial characterisation are documented in metabolic research literature examining peptides encoded outside the nuclear genome.
Metabolic regulation research
Rodent studies have reported that MOTS-c administration influences glucose homeostasis and insulin sensitivity, with research describing activation of the AMPK signalling pathway as a proposed mechanism. This line of research has extended to diet-induced obesity models, where studies have reported changes in metabolic parameters associated with AMPK pathway engagement.
Mitochondrial-nuclear communication
Under conditions of metabolic stress, research has reported that MOTS-c translocates to the nucleus, where it has been described as interacting with stress-responsive transcription factors including NRF2. This research programme positions MOTS-c as a signalling molecule that coordinates mitochondrial and nuclear gene expression, a mechanism studied across several independent laboratories.
Exercise physiology research
Because MOTS-c is expressed in skeletal muscle and modulated by metabolic demand, exercise physiology studies have examined circulating MOTS-c levels in relation to physical activity in both animal models and human cohort research. This has positioned MOTS-c as a research tool for studying the molecular links between mitochondrial function and exercise-induced metabolic adaptation.
Ageing research
Circulating MOTS-c levels have been reported to decline with age in cohort studies, a finding that has extended MOTS-c research into the broader mitochondrial-ageing literature alongside other metabolic compounds in this catalogue's LEAN and FOCUS categories, such as NAD+. Animal studies have used MOTS-c administration as a tool to examine whether restoring peptide levels affects age-associated metabolic decline.
Comparative mitochondrial-derived peptide research
MOTS-c is studied alongside other mitochondrial-derived peptides, most notably humanin, in comparative research examining how peptides encoded within mitochondrial DNA contribute to cell-autonomous and systemic metabolic signalling, a research area that remains under active investigation across independent laboratories.
Laboratory handling
MOTS-c should be stored as lyophilised powder at -20°C, protected from light and moisture, until reconstitution. Reconstitution follows standard peptide practice: diluent introduced slowly along the vial wall, followed by gentle mixing rather than shaking.
- Lyophilised powder: store at -20°C, protected from light, until reconstitution.
- Reconstitution: introduce diluent slowly along the vial wall; mix gently, do not shake.
- Post-reconstitution: 2-8°C for short-term laboratory use; avoid repeated freeze-thaw cycles.
- Each batch ships with a certificate of analysis confirming ≥99% purity by HPLC and identity by mass spectrometry.
See the peptide reconstitution and storage guide for a full protocol reference. This product is intended for laboratory research use only.
References
- Lee C, Zeng J, Drew BG, et al. “The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance”. Cell Metabolism, 2015. PubMed / DOI
- Lee C, Kim KH, Cohen P. “MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism”. Free Radical Biology and Medicine, 2016. PubMed / DOI
- Reynolds JC, Lai RW, Woodhead JST, et al. “MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis”. Nature Communications, 2021. PubMed / DOI


















